Malattie rare, intervista a Vittorio Maglione ricercatore Neuromed - Adnkronos.com
Il ricercatore Vittorio Maglione alla prestigiosa Gordon Conference – quotidianomolise.com
Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience
PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease
PDF) Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
2.Elena-Cattaneo-con-Alba-di-Pardo-e-Vittorio-Maglione.jpg - TeleRegione Molise
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
MALATTIE RARE. L'IMPORTANZA DELLA CONOSCENZA | inSalute – Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
POZZILLI – Il ricercatore Neuromed, Vittorio Maglione, al congresso della Gordon Rearch Conference per presentare i suoi lavori. – Paese News cronaca politica sport caserta e provincia
Vittorio Maglione (@VittorioMaglio1) / Twitter
IL VIDEO CORONAVIRUS. Ipotesi Neuromed sugli sfingolipidi. Lo studio pubblicato sul British Medical Journal - CasertaCE
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Telethon finanzia la ricerca Neuromed: Vittorio Maglione, lab malattie rare - YouTube
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
